Amin Ullah
Amin Ullah
邮箱：amindawar225@gmail.com
职位：博士后
研究方向：
常见生殖障碍相关的炎症生物标志物：多囊卵巢综合征（PCOS）、子宫内膜异位症、先兆子痫等。研究生殖相关癌症，如乳腺癌症、卵巢癌症、前列腺癌症等，以及代谢紊乱，如2型糖尿病、衰老、非酒精性脂肪肝等。我目前的研究重点是引入炎症基因或免疫炎症生物标志物，如细胞因子、趋化因子和免疫炎症相关细胞。
关键词：多囊卵巢综合征，癌症，免疫炎症生物标志物，代谢紊乱。
合作导师：沈百荣
教育、工作经历：重庆医科大学 免疫学 博士
学术、研究成果：
国家级奖项：
收到巴基斯坦总理赠送的笔记本电脑及配件。
欠发达地区费用偿还计划的奖学金持有者。
国际级奖项：
中国政府博士项目奖学金获得者（2018-2022）。
国际学生创新大赛（第二届成渝经济圈）第二名。在与成都、重庆的20个企业和高校团队竞争后，我作为领导者获得了“优秀项目奖”，重庆大学获得了“卓越组织奖”。
E-mail: amindawar225@gmail.com
Position: Postdoctoral Researcher
Research interest:
I focused on the analysis of inflammatory biomarkers that are
related to the most common reproductive disorders: polycystic ovarian
syndrome (PCOS), Endometriosis, Preeclampsia, etc.; reproductive-related
cancers such as Breast cancer, Ovarian cancer, Prostate cancer, etc.;
and Metabolic disorders such as Type 2 diabetes, Aging, Non-alcoholic
fatty liver diseases, etc. My current research focuses on introducing
inflammatory genes or immunological inflammatory biomarkers such as
cytokines, chemokines, and immune inflammation-related cells.
Keywords: PCOS, cancers, immunological inflammatory biomarkers, metabolic disorders.
Cooperative tutor: Bairong Shen
Education and work experiences:
PhD in immunology. Some of my previous published work is listed below.
Research and achievements:
National level awards:
Received laptop and accessories from Prime Minister of Pakistan.
Scholarship holder of fee reimbursement Scheme for less developed areas.
International level awards:
An awardee of the Chines Government Scholarship for Ph.D. Program (2018-2022).
2nd position in the innovation competition for
international students (The Second Chengdu-Chongqing Economics Circle).
After competing with 20 teams from enterprises and universities in
Chengdu and Chongqing, I won an "Excellent Project Award" as a leader,
and CQMU earned an "Excellent Organization Award".
Publications:
I have published a total of 11 articles, including 2 review articles
by West China Hospital as the first unit, both articles by West China
C-level journals, and three review articles are now under review in the
category of C journals, and one is ready to submit.